Universe · entity
Tetragon Partners GP Ltd
Institutional manager (13F) · CIK 1515070
13F holdings · as of 2026-03-31 · top 34 · reported portfolio $509M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | UIPATH INC | $280M | 25,207,628 |
| 2 | KOLIBRI GLOBAL ENERGY INC | $38M | 6,834,504 |
| 3 | WARNER BROS DISCOVERY INC | $25M | 923,725 |
| 4 | WORKIVA INC | $15M | 250,000 |
| 5 | LYFT INC | $13M | 1,000,000 |
| 6 | SPRINKLR INC | $13M | 2,200,000 |
| 7 | AUTOLUS THERAPEUTICS LTD | $13M | 9,500,000 |
| 8 | CELLDEX THERAPEUTICS INC NEW | $10M | 312,316 |
| 9 | ARROWHEAD PHARMACEUTICALS IN | $8M | 127,198 |
| 10 | NEKTAR THERAPEUTICS | $7M | 103,037 |
| 11 | ANNEXON INC | $7M | 1,292,455 |
| 12 | PHARVARIS N V | $6M | 221,611 |
| 13 | ALKERMES PLC | $6M | 159,791 |
| 14 | AGIOS PHARMACEUTICALS INC | $6M | 164,839 |
| 15 | IMMUNOVANT INC | $5M | 218,507 |
| 16 | PRAXIS PRECISION MEDICINES I | $5M | 15,952 |
| 17 | KRYSTAL BIOTECH INC | $5M | 19,668 |
| 18 | DYNE THERAPEUTICS INC | $5M | 258,132 |
| 19 | AMYLYX PHARMACEUTICALS INC | $4M | 317,877 |
| 20 | MBX BIOSCIENCES INC | $4M | 145,480 |
| 21 | DEFINIUM THERAPEUTICS INC | $4M | 199,994 |
| 22 | SOLENO THERAPEUTICS INC | $3M | 102,125 |
| 23 | AXSOME THERAPEUTICS INC. | $3M | 20,059 |
| 24 | HARMONY BIOSCIENCES HLDGS IN | $3M | 119,340 |
| 25 | SILENCE THERAPEUTICS PLC | $3M | 630,161 |
| 26 | ACADIA PHARMACEUTICALS INC | $3M | 144,620 |
| 27 | IONIS PHARMACEUTICALS INC | $3M | 41,764 |
| 28 | MAPLIGHT THERAPEUTICS INC | $2M | 112,115 |
| 29 | RELAY THERAPEUTICS INC | $2M | 181,543 |
| 30 | SNOWFLAKE INC | $2M | 10,000 |
| 31 | AARDVARK THERAPEUTICS INC | $1M | 316,621 |
| 32 | TECTONIC THERAPEUTIC INC | $1M | 37,588 |
| 33 | ULTRAGENYX PHARMACEUTICAL IN | $827k | 39,473 |
| 34 | KARYOPHARM THERAPEUTICS INC | $295k | 52,984 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.